Santhera Receives Positive NICE Final Guidance for AGAMREE® (Vamorolone) as a Treatment ...
Santhera has begun launch preparations for AGAMREE® in UK with first sales expected in this quarterPratteln, Switzerland, January 16, 2025 – ...
The FDA has banned Red No. 3, a synthetic dye used in candy, cereals, and ADHD medication
Red No. 3, a synthetic dye that gives a cherry hue to candies, sodas, and some medications, has been linked to cancer in some ...
Acadia Pharmaceuticals submits trofinetide MAA to EMA
Acadia Pharmaceuticals (ACAD) announced that the company has submitted a marketing authorization application to the European Medicines Agency ...
Cytokinetics, Incorporated: Cytokinetics Announces 2025 Corporate Milestones and Vision 2030
PDUFA Target Action Date for Aficamten Set for September 26, 2025;Commercial Launch Preparations Underway for First Potential Approval Five-Year Aspirations Outline Corporate Strategies to Becoming Le ...